1 Trademark Results found for "CERVATEC"

Also try searching for:

CERVATEC*

CERV*

*TEC

CE*EC

Mark	Details	Status	Class/Description
	CERVATEC ROCHE DIAGNOSTICS GMBH 1317485 21 Sept 2006	EXPUNGED on 3 Apr 2024	Diagnostic preparations, reagents and test kits for detection of cance... Class 001 Class 001 Chemical Products Diagnostic preparations, reagents and test kits for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors, all for scientific or research use; veterinary preparations for the treatment and prevention of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits for detection of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer; medical diagnostic preparations namely in-vitro and in-vivo diagnostic testkits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits; medical diagnostic testing machines, namely point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; diagnostic equipment namely containers, vessels, tubes, multiwell-plates, columns, stripes, sticks, brushes, syringes, needles, spatulas, swabs, clothes, tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above; diagnostic apparatuses and instruments namely hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic (electro)magnetic-resonance, histological, microscopic or in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above for clinical and medical laboratory use. Class 005 Class 005 Pharmaceutical Products Scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services; medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds. ... Class 009 Computer & Software Products & Electrical & Scientific Products Class 010 Medical Instrument Products Class 042 Computer & Software Services & Scientific Services Class 044 Medical, Beauty & Agricultural Services

EXPUNGED

on 3 Apr 2024

CERVATEC

ROCHE DIAGNOSTICS GMBH

1317485 · 21 Sept 2006

001

Class 001

Chemical Products

Diagnostic preparations, reagents and test kits for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors, all for scientific or research use; veterinary preparations for the treatment and prevention of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits for detection of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer; medical diagnostic preparations namely in-vitro and in-vivo diagnostic testkits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits; medical diagnostic testing machines, namely point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; diagnostic equipment namely containers, vessels, tubes, multiwell-plates, columns, stripes, sticks, brushes, syringes, needles, spatulas, swabs, clothes, tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above; diagnostic apparatuses and instruments namely hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic (electro)magnetic-resonance, histological, microscopic or in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of neoplastic diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, inflammatory diseases, namely inflammatory diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract infectious diseases, namely infectious diseases of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, namely premalignant and malignant cancerous conditions of the male and female reproductive organs, of the genital tract, of the urinary tract and of the anogenital tract, cervical intraepithelial neoplasia, carcinoma in situ and cancer as indicated above for clinical and medical laboratory use.

005

...

Diagnostic preparations, reagents and test kits for detection of cance...

Owners

Roche diagnostics gmbh (1)

Categories

Class 1 (1)

Class 5 (1)

Class 9 (1)

Class 10 (1)

Class 42 (1)

Class 44 (1)

Correspondents

Gowling wlg (canada) llp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$138/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$691/ 1 class + gov fee

European Union

C$969/ 1 class + gov fee

China

C$691/ 1 class + gov fee

South Korea

C$968/ 1 class + gov fee

Japan

C$1,106/ 1 class + gov fee

India

C$138/ 1 class + gov fee

United Kingdom

C$691/ 1 class + gov fee

Australia

C$414/ 1 class + gov fee

Israel

C$968/ 1 class + gov fee

United Arab Emirates

C$968/ 1 class + gov fee

New Zealand

C$968/ 1 class + gov fee

Brazil

C$691/ 1 class + gov fee

Taiwan

C$1,106/ 1 class + gov fee

Ukraine

C$1,106/ 1 class + gov fee

Indonesia

C$968/ 1 class + gov fee

South Africa

C$691/ 1 class + gov fee

Singapore

C$1,106/ 1 class + gov fee

Saudi Arabia

C$1,106/ 1 class + gov fee

Afghanistan

C$1,106/ 1 class + gov fee

Algeria

C$1,106/ 1 class + gov fee

Argentina

C$553/ 1 class + gov fee

Austria

C$1,245/ 1 class + gov fee

Bahrain

C$968/ 1 class + gov fee

Bangladesh

C$829/ 1 class + gov fee

Benelux

C$1,383/ 1 class + gov fee

Bhutan

C$1,245/ 1 class + gov fee

Bolivia

C$1,106/ 1 class + gov fee

Botswana

C$1,798/ 1 class + gov fee

British Virgin Islands

C$1,660/ 1 class + gov fee

Bulgaria

C$1,106/ 1 class + gov fee

Cambodia

C$1,106/ 1 class + gov fee

Chile

C$691/ 1 class + gov fee

Colombia

C$968/ 1 class + gov fee

Congo

C$1,660/ 1 class + gov fee

Costa Rica

C$1,245/ 1 class + gov fee

Croatia

C$1,245/ 1 class + gov fee

Cyprus

C$1,383/ 1 class + gov fee

Czech Republic

C$1,245/ 1 class + gov fee

Denmark

C$1,106/ 1 class + gov fee

Curacao

C$1,660/ 1 class + gov fee

Macau

C$968/ 1 class + gov fee

Dominican Republic

C$1,245/ 1 class + gov fee

Aruba

C$1,660/ 1 class + gov fee

Greenland

C$1,106/ 1 class + gov fee

Ecuador

C$1,106/ 1 class + gov fee

Egypt

C$968/ 1 class + gov fee

El Salvador

C$1,106/ 1 class + gov fee

Ethiopia

C$1,521/ 1 class + gov fee

France

C$1,245/ 1 class + gov fee

Gaza

C$1,106/ 1 class + gov fee

Germany

C$1,245/ 1 class + gov fee

Greece

C$1,106/ 1 class + gov fee

Guatemala

C$1,245/ 1 class + gov fee

Haiti

C$1,245/ 1 class + gov fee

Honduras

C$1,245/ 1 class + gov fee

Hong Kong (SAR)

C$1,245/ 1 class + gov fee

Hungary

C$1,521/ 1 class + gov fee

Iraq

C$2,075/ 1 class + gov fee

Italy

C$1,245/ 1 class + gov fee

Jordan

C$1,106/ 1 class + gov fee

Kazakhstan

C$1,106/ 1 class + gov fee

Kenya

C$1,245/ 1 class + gov fee

Kuwait

C$1,106/ 1 class + gov fee

Laos

C$968/ 1 class + gov fee

Lebanon

C$1,383/ 1 class + gov fee

Lesotho

C$1,660/ 1 class + gov fee

Libya

C$1,245/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,767/ 1 class + gov fee

Malawi

C$1,521/ 1 class + gov fee

Malaysia

C$968/ 1 class + gov fee

Maldives

C$1,383/ 1 class + gov fee

Morocco

C$1,383/ 1 class + gov fee

Mozambique

C$1,245/ 1 class + gov fee

Myanmar

C$1,106/ 1 class + gov fee

Namibia

C$1,106/ 1 class + gov fee

Nepal

C$968/ 1 class + gov fee

Nicaragua

C$1,245/ 1 class + gov fee

Norway

C$1,245/ 1 class + gov fee

Oman

C$1,521/ 1 class + gov fee

Pakistan

C$1,106/ 1 class + gov fee

Panama

C$1,245/ 1 class + gov fee

Paraguay

C$1,245/ 1 class + gov fee

Peru

C$1,106/ 1 class + gov fee

Philippines

C$1,245/ 1 class + gov fee

Poland

C$691/ 1 class + gov fee

Portugal

C$1,245/ 1 class + gov fee

Puerto Rico

C$1,245/ 1 class + gov fee

Qatar

C$1,106/ 1 class + gov fee

Romania

C$1,245/ 1 class + gov fee

Serbia

C$1,245/ 1 class + gov fee

Slovakia

C$1,245/ 1 class + gov fee

Spain

C$1,245/ 1 class + gov fee

Sri Lanka

C$968/ 1 class + gov fee

Swaziland

C$1,798/ 1 class + gov fee

Sweden

C$1,106/ 1 class + gov fee

Switzerland

C$1,245/ 1 class + gov fee

Thailand

C$1,106/ 1 class + gov fee

Tunisia

C$1,245/ 1 class + gov fee

Turkey

C$1,106/ 1 class + gov fee

Uganda

C$968/ 1 class + gov fee

United Republic of Tanzania

C$968/ 1 class + gov fee

Uruguay

C$1,106/ 1 class + gov fee

Venezuela

C$1,245/ 1 class + gov fee

Vietnam

C$1,106/ 1 class + gov fee

West Bank, Palestine

C$1,106/ 1 class + gov fee

Yemen

C$2,352/ 1 class + gov fee

Albania

C$1,245/ 1 class + gov fee

Andorra

C$1,245/ 1 class + gov fee

Angola

C$1,798/ 1 class + gov fee

Antigua and Barbuda

C$1,660/ 1 class + gov fee

Armenia

C$1,106/ 1 class + gov fee

Azerbaijan

C$1,106/ 1 class + gov fee

Bahamas

C$1,937/ 1 class + gov fee

Barbados

C$1,798/ 1 class + gov fee

Belgium

C$1,383/ 1 class + gov fee

Belize

C$1,798/ 1 class + gov fee

Benin

C$1,106/ 1 class + gov fee

Bosnia and Herzegovina

C$1,383/ 1 class + gov fee

Brunei

C$1,798/ 1 class + gov fee

Burkina Faso

C$1,106/ 1 class + gov fee

Burundi

C$1,660/ 1 class + gov fee

Cabo Verde

C$1,245/ 1 class + gov fee

Cameroon

C$1,106/ 1 class + gov fee

Central African Republic (CAR)

C$1,106/ 1 class + gov fee

Chad

C$1,106/ 1 class + gov fee

Comoros

C$1,106/ 1 class + gov fee

Cote d'Ivoire

C$1,106/ 1 class + gov fee

Czechia

C$1,383/ 1 class + gov fee

Djibouti

C$1,660/ 1 class + gov fee

Dominica

C$1,798/ 1 class + gov fee

Equatorial Guinea

C$1,106/ 1 class + gov fee

Eritrea

C$1,383/ 1 class + gov fee

Estonia

C$1,798/ 1 class + gov fee

Eswatini

C$1,798/ 1 class + gov fee

Fiji

C$1,245/ 1 class + gov fee

Finland

C$968/ 1 class + gov fee

Gabon

C$1,106/ 1 class + gov fee

Gambia

C$1,245/ 1 class + gov fee

Georgia

C$1,106/ 1 class + gov fee

Ghana

C$1,383/ 1 class + gov fee

Grenada

C$1,798/ 1 class + gov fee

Guinea

C$1,106/ 1 class + gov fee

Guinea-Bissau

C$1,106/ 1 class + gov fee

Guyana

C$1,798/ 1 class + gov fee

Iceland

C$1,798/ 1 class + gov fee

Ireland

C$1,106/ 1 class + gov fee

Jamaica

C$1,660/ 1 class + gov fee

Kiribati

C$1,383/ 1 class + gov fee

Kosovo

C$1,245/ 1 class + gov fee

Kyrgyzstan

C$1,245/ 1 class + gov fee

Latvia

C$968/ 1 class + gov fee

Liberia

C$1,383/ 1 class + gov fee

Liechtenstein

C$1,383/ 1 class + gov fee

Lithuania

C$968/ 1 class + gov fee

Luxembourg

C$1,383/ 1 class + gov fee

Madagascar

C$1,383/ 1 class + gov fee

Mali

C$1,106/ 1 class + gov fee

Malta

C$829/ 1 class + gov fee

Marshall Islands

C$1,383/ 1 class + gov fee

Mauritania

C$1,106/ 1 class + gov fee

Mauritius

C$1,383/ 1 class + gov fee

Micronesia

C$1,383/ 1 class + gov fee

Moldova

C$1,383/ 1 class + gov fee

Monaco

C$1,937/ 1 class + gov fee

Mongolia

C$829/ 1 class + gov fee

Montenegro

C$1,245/ 1 class + gov fee

Nauru

C$1,383/ 1 class + gov fee

Netherlands

C$1,383/ 1 class + gov fee

Niger

C$1,106/ 1 class + gov fee

Nigeria

C$553/ 1 class + gov fee

North Macedonia

C$1,245/ 1 class + gov fee

Palau

C$1,383/ 1 class + gov fee

Palestine

C$1,383/ 1 class + gov fee

Papua New Guinea

C$1,106/ 1 class + gov fee

Rwanda

C$1,383/ 1 class + gov fee

Saint Kitts and Nevis

C$1,798/ 1 class + gov fee

Saint Lucia

C$1,798/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,798/ 1 class + gov fee

Samoa

C$1,660/ 1 class + gov fee

San Marino

C$1,383/ 1 class + gov fee

Sao Tome and Principe

C$1,383/ 1 class + gov fee

Senegal

C$1,106/ 1 class + gov fee

Seychelles

C$1,383/ 1 class + gov fee

Sierra Leone

C$1,383/ 1 class + gov fee

Slovenia

C$1,245/ 1 class + gov fee

Solomon Islands

C$1,383/ 1 class + gov fee

Somalia

C$1,383/ 1 class + gov fee

South Sudan

C$1,383/ 1 class + gov fee

Suriname

C$2,213/ 1 class + gov fee

Tajikistan

C$1,106/ 1 class + gov fee

Tanzania

C$968/ 1 class + gov fee

Timor-Leste

C$1,383/ 1 class + gov fee

Togo

C$1,106/ 1 class + gov fee

Tonga

C$1,798/ 1 class + gov fee

Trinidad and Tobago

C$1,660/ 1 class + gov fee

Turkmenistan

C$1,106/ 1 class + gov fee

Tuvalu

C$1,383/ 1 class + gov fee

Uzbekistan

C$968/ 1 class + gov fee

Vanuatu

C$1,660/ 1 class + gov fee

Zambia

C$1,245/ 1 class + gov fee

Zimbabwe

C$1,245/ 1 class + gov fee

OAPI

C$1,245/ 1 class + gov fee

ARIPO

C$1,383/ 1 class + gov fee

End of search results

Page 1 of 1